Search Results for "patient education"

“The way I approach patient education conversations is to discuss it, address it, but not to emphasize it. I really like to focus on what the drug is. I mention if it’s a biosimilar, I explain it, I give resources if they want it, but I really try to focus on the things that they’re going to need to know in order to help be part of their care, but have readily available information to give them if they want more,” ONS affiliate member Rowena (Moe) Schwartz, PharmD, BCOP, professor of pharmacy practice at the University of Cincinnati in Ohio, told Jaime Weimer, MSN, RN, AGCNS-BC, AOCNS^®, oncology clinical specialist at ONS during a discussion about the basics of biosimilars for nurses and patients.

ONS member Kristi Orbaugh, RN, MSN, RNP, AOCN^®, nurse practitioner for Community Hospital Oncology Physicians in Indianapolis, IN, and member of the Central Indiana ONS Chapter, joins Stephanie Jardine, BSN, RN, oncology clinical specialist at ONS, to discuss patient education prior to and during immunotherapy. This is a continued conversation from a previous episode that discussed findings from an ONS focus group that Orbaugh facilitated in August 2021; we’ve linked that in the episode notes. This podcast episode is supported by an educational grant from AstraZeneca. ONS is solely responsible for the criteria, objectives, content, quality, and scientific integrity of its programs and publications. 

ONS member Tracy Wyant, DNP, AOCN^®, CHPN, director of cancer information at the American Cancer Society (ACS), joins Chris Pirschel by phone to discuss ACS’s patient education resources, healthcare provider programs, available services for caregivers, and much more.

ONS member Susan Rawl, PhD, RN, FAAHB, FAAN, professor in the science and nursing care department and director of the Advanced Training in Self-Management Interventions Program at Indiana University School of Nursing in Indianapolis, and member of the Central Indiana ONS Chapter, joins Chris Pirschel, ONS staff writer/producer, to discuss barriers to patient education, how healthcare disparities affect education delivery, and ways nurses can overcome challenges to support patient needs.

This episode was supported by funding from Mylan.

ONS member Kristi Orbaugh, RN, MSN, RNP, AOCN^®, nurse practitioner for Community Hospital Oncology Physicians in Indianapolis, IN, and member of the Central Indiana ONS Chapter, joins Chris Pirschel, ONS staff writer/producer, to discuss what nurses need to know about biosimilars, the need for biosimilar patient education resources, and how ONS and its members can move the needle for the future of biosimilars.

“What does the patient need to know? What are their knowledge gaps? What are they most in need of? Once you determine the areas you need to pinpoint, branded or nonbranded, then there’s resources out there for you to use,” Chelsea Backler, MSN, APRN, AGCNS-BC, AOCNS^®, VA-BC, oncology clinical specialist at ONS, told Stephanie Jardine, BSN, RN, oncology clinical specialist at ONS. Backler explained the differences between branded and nonbranded patient education resources, ways for oncology nurses to identify credible resources, and ONS’s Seal of Approval Program for branded and nonbranded resources. You can earn free NCPD contact hours by completing the evaluation linked below.

ONS member Amanda Sarafin, BSN, OCN^®, MSN/Ed, nurse manager at Mount Sinai Health System in New York, NY, joins Stephanie Jardine, BSN, RN, oncology clinical specialist at ONS, to discuss how oncology nurses and patients can find reputable educational resources during all stages of cancer care.

How do you know that your patients are prepared to receive your education? Do you have the right educational tools and resources for their level of learning and retention? Are you sure your patients understand what you’ve taught them? ONS member Beau Amaya, MSN, RN, OCN^®, associate director of patient education and engagement at Memorial Sloan Kettering Cancer Center in New York, NY, and member of the New York City ONS Chapter, joins Stephanie Jardine, BSN, RN, oncology clinical specialist at ONS, to discuss what nurses should consider when delivering patient education assessments for all phases of the treatment plan.

“Nurses can bridge the information gap and help patients better understand that the information received from next-generation sequencing (NGS) can really help to determine which treatment they will respond best to, if there are therapies that won’t be effective, or if there are clinical trials that are open to them based on the results,” Danielle Fournier, RN, MSN, APRN, AGPCNP-BC, AOCNP^®, CORLN, advanced practice RN in the department of thoracic surgery at MD Anderson Cancer Center in Houston, TX, told Stephanie Jardine, BSN, RN, oncology clinical specialist at ONS. Fournier discussed the advancements being made in NGS technology and how it can be used to care for patients with cancer.

Cancer disease and treatment can alter many aspects of sexual health, but patient concerns often remain unverbalized and unaddressed. Oncology nurses can push through awkwardness and provide resources to help patients rediscover intimacy during and after cancer. ONS member Marloe Esch, RN, BSN, OCN^®, breast care nurse navigator at Froedtert and the Medical College of Wisconsin and member of the Southeastern Wisconsin ONS Chapter, joins Stephanie Jardine, BSN, RN, oncology clinical specialist at ONS, to discuss how nurses can talk to their patients about sex and strategies for becoming more comfortable with those conversations. The advertising messages in this episode are paid for by Breast Cancer Index.